These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 17766533

  • 1. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age.
    O'Shea TM, Washburn LK, Nixon PA, Goldstein DJ.
    Pediatrics; 2007 Sep; 120(3):594-602. PubMed ID: 17766533
    [Abstract] [Full Text] [Related]

  • 2. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.
    Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB, DART Study Investigators.
    Pediatrics; 2007 Apr; 119(4):716-21. PubMed ID: 17403842
    [Abstract] [Full Text] [Related]

  • 3. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.
    O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG, Dillard RG.
    Pediatrics; 1999 Jul; 104(1 Pt 1):15-21. PubMed ID: 10390254
    [Abstract] [Full Text] [Related]

  • 4. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins RD, National Institute of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [Abstract] [Full Text] [Related]

  • 5. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s.
    Wilson-Costello D, Friedman H, Minich N, Fanaroff AA, Hack M.
    Pediatrics; 2005 Apr; 115(4):997-1003. PubMed ID: 15805376
    [Abstract] [Full Text] [Related]

  • 6. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ, Anbar RD, Mettelman BB.
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [Abstract] [Full Text] [Related]

  • 7. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C, Bowling S, Williamson K, McGaw P, Durand M.
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [Abstract] [Full Text] [Related]

  • 8. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F, Sinha S, Gadzinowski J, D'Agostino R, Segal R, Guardia C, Mazela J, Liu G, SELECT and STAR Study Investigators.
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [Abstract] [Full Text] [Related]

  • 9. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.
    Mieskonen S, Eronen M, Malmberg LP, Turpeinen M, Kari MA, Hallman M.
    Acta Paediatr; 2003 Aug; 92(8):896-904. PubMed ID: 12948063
    [Abstract] [Full Text] [Related]

  • 10. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.
    Bierer R, Peceny MC, Hartenberger CH, Ohls RK.
    Pediatrics; 2006 Sep; 118(3):e635-40. PubMed ID: 16908620
    [Abstract] [Full Text] [Related]

  • 11. Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age.
    Washburn LK, Nixon PA, O'Shea TM.
    Pediatrics; 2006 Oct; 118(4):1592-9. PubMed ID: 17015551
    [Abstract] [Full Text] [Related]

  • 12. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes.
    Jones RA, Collaborative Dexamethasone Trial Follow-up Group.
    Pediatrics; 2005 Aug; 116(2):370-8. PubMed ID: 16061591
    [Abstract] [Full Text] [Related]

  • 13. Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants.
    Kothadia JM, O'Shea TM, Roberts D, Auringer ST, Weaver RG, Dillard RG.
    Pediatrics; 1999 Jul; 104(1 Pt 1):22-7. PubMed ID: 10390255
    [Abstract] [Full Text] [Related]

  • 14. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.
    Ohls RK, Ehrenkranz RA, Das A, Dusick AM, Yolton K, Romano E, Delaney-Black V, Papile LA, Simon NP, Steichen JJ, Lee KG, National Institute of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109
    [Abstract] [Full Text] [Related]

  • 15. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis.
    Onland W, De Jaegere AP, Offringa M, van Kaam AH.
    Pediatrics; 2008 Jul; 122(1):92-101. PubMed ID: 18595991
    [Abstract] [Full Text] [Related]

  • 16. Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up.
    Jones R, Wincott E, Elbourne D, Grant A.
    Pediatrics; 1995 Nov; 96(5 Pt 1):897-906. PubMed ID: 7478833
    [Abstract] [Full Text] [Related]

  • 17. Infants of less than 1250 grams birth weight at Groote Schuur Hospital: outcome at 1 and 2 years of age.
    Thompson CM, Buccimazza SS, Webster J, Malan AF, Molteno CD.
    Pediatrics; 1993 May; 91(5):961-8. PubMed ID: 8474817
    [Abstract] [Full Text] [Related]

  • 18. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
    Rozycki HJ, Byron PR, Elliott GR, Carroll T, Gutcher GR.
    Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
    [Abstract] [Full Text] [Related]

  • 19. Neurodevelopmental outcomes of premature infants treated with l-arginine for prevention of necrotising enterocolitis.
    Amin HJ, Soraisham AS, Sauve RS.
    J Paediatr Child Health; 2009 Apr; 45(4):219-23. PubMed ID: 19320804
    [Abstract] [Full Text] [Related]

  • 20. Major congenital anomalies place extremely low birth weight infants at higher risk for poor growth and developmental outcomes.
    Walden RV, Taylor SC, Hansen NI, Poole WK, Stoll BJ, Abuelo D, Vohr BR, National Institute of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2007 Dec; 120(6):e1512-9. PubMed ID: 17984212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.